The College of American Pathologists and the American Society of Clinical Oncology on December 11 announced the release of a clinical practice guideline to improve the accuracy of HER2 testing for breast cancer patients and to guide therapy selection. This is the first time the two groups have joined to address a critical issue affecting all patients with a new diagnosis of invasive breast cancer, said CAP and ASCO in a joint statement.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

December 15, 2006 - Table of Contents

NIR December 15, 2006 (full PDF issue)

Pathology Escapes SGR Fee Cut, but Not Other Reductions

CMS Finalizes 2007 Lab Fee Schedule

‘Grandfather’ Protection Extended for Pathology TC Billings

What’s Ahead for Clinical Labs, Pathologists in ’07? A Quick Guide to Key Medicare Policy Changes

New Practice Guideline for HER2 Testing for Breast Cancer

New Waived Tests & Billing Codes

Medicare Recovery Audit Project to Go Nationwide

After Contentious Struggle, FDA Gets Permanent Head